1.
Stephen Langabeer. Molecular screening for an underlying myeloproliferative neoplasm in rheumatology patients. Archives of Rheumatology [Internet]. 2022 Sep. 30 [cited 2025 Oct. 19];37(3):475-6. Available from: https://www.archivesofrheumatology.org/index.php/pub/article/view/1289